Literature DB >> 28508995

L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain.

Gustavo C Ferreira1,2, Mary C McKenna3,4.   

Abstract

L-Carnitine functions to transport long chain fatty acyl-CoAs into the mitochondria for degradation by β-oxidation. Treatment with L-carnitine can ameliorate metabolic imbalances in many inborn errors of metabolism. In recent years there has been considerable interest in the therapeutic potential of L-carnitine and its acetylated derivative acetyl-L-carnitine (ALCAR) for neuroprotection in a number of disorders including hypoxia-ischemia, traumatic brain injury, Alzheimer's disease and in conditions leading to central or peripheral nervous system injury. There is compelling evidence from preclinical studies that L-carnitine and ALCAR can improve energy status, decrease oxidative stress and prevent subsequent cell death in models of adult, neonatal and pediatric brain injury. ALCAR can provide an acetyl moiety that can be oxidized for energy, used as a precursor for acetylcholine, or incorporated into glutamate, glutamine and GABA, or into lipids for myelination and cell growth. Administration of ALCAR after brain injury in rat pups improved long-term functional outcomes, including memory. Additional studies are needed to better explore the potential of L-carnitine and ALCAR for protection of developing brain as there is an urgent need for therapies that can improve outcome after neonatal and pediatric brain injury.

Entities:  

Keywords:  Acetyl-L-carnitine; Carnitine shuttle; Inborn errors of metabolism; L-Carnitine; Metabolism; Neonatal hypoxia-ischemia; Neuroprotection; Pediatric traumatic brain injury

Mesh:

Substances:

Year:  2017        PMID: 28508995      PMCID: PMC5621476          DOI: 10.1007/s11064-017-2288-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  167 in total

1.  Carnitine supplementation alleviates lipid metabolism derangements and protects against oxidative stress in non-obese hereditary hypertriglyceridemic rats.

Authors:  Monika Cahova; Petr Chrastina; Hana Hansikova; Zdenek Drahota; Jaroslava Trnovska; Vojtech Skop; Jana Spacilova; Hana Malinska; Olena Oliyarnyk; Zuzana Papackova; Eliska Palenickova; Ludmila Kazdova
Journal:  Appl Physiol Nutr Metab       Date:  2015-03       Impact factor: 2.665

Review 2.  Metabolic Alterations in Developing Brain After Injury: Knowns and Unknowns.

Authors:  Mary C McKenna; Susanna Scafidi; Courtney L Robertson
Journal:  Neurochem Res       Date:  2015-07-07       Impact factor: 3.996

3.  Activity of L-carnitine and L-acetylcarnitine on cholinoceptive neocortical neurons of the rat in vivo.

Authors:  L Janiri; M Falcone; A Persico; E Tempesta
Journal:  J Neural Transm Gen Sect       Date:  1991

4.  Anti-apoptotic effect of acetyl-l-carnitine and I-carnitine in primary cultured neurons.

Authors:  T Ishii; Y Shimpo; Y Matsuoka; K Kinoshita
Journal:  Jpn J Pharmacol       Date:  2000-06

5.  Carnitine treatment inhibits increases in cerebral carnitine esters and glutamate detected by mass spectrometry after hypoxia-ischemia in newborn rats.

Authors:  Mark S Wainwright; Rohit Kohli; Peter F Whitington; Donald H Chace
Journal:  Stroke       Date:  2005-12-29       Impact factor: 7.914

6.  The effects of L-carnitine on the combination of, inhalation anesthetic-induced developmental, neuronal apoptosis in the rat frontal cortex.

Authors:  X Zou; N Sadovova; T A Patterson; R L Divine; C E Hotchkiss; S F Ali; J P Hanig; M G Paule; W Slikker; C Wang
Journal:  Neuroscience       Date:  2007-12-15       Impact factor: 3.590

7.  Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency.

Authors:  C R Roe; D S Millington; D A Maltby; T P Bohan; S G Kahler; R A Chalmers
Journal:  Pediatr Res       Date:  1985-05       Impact factor: 3.756

8.  The pentose phosphate pathway and pyruvate carboxylation after neonatal hypoxic-ischemic brain injury.

Authors:  Eva M F Brekke; Tora S Morken; Marius Widerøe; Asta K Håberg; Ann-Mari Brubakk; Ursula Sonnewald
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-05       Impact factor: 6.200

9.  Effects of acetyl-L-carnitine on regional cerebral glucose metabolism in awake rats.

Authors:  Carlo Ori; Ulderico Freo; Gilberto Pizzolato; Mauro Dam
Journal:  Brain Res       Date:  2002-10-04       Impact factor: 3.252

10.  Brain and muscle redox imbalance elicited by acute ethylmalonic acid administration.

Authors:  Patrícia Fernanda Schuck; Ana Paula Milanez; Francine Felisberto; Leticia Selinger Galant; Jéssica Luca Machado; Camila Brulezi Furlanetto; Fabricia Petronilho; Felipe Dal-Pizzol; Emilio Luiz Streck; Gustavo Costa Ferreira
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

View more
  51 in total

1.  Effect of Acetyl-L-carnitine Used for Protection of Neonatal Hypoxic-Ischemic Brain Injury on Acute Kidney Changes in Male and Female Rats.

Authors:  Andrew G Wang; Michele Diamond; Jaylyn Waddell; Mary C McKenna
Journal:  Neurochem Res       Date:  2019-04-30       Impact factor: 3.996

2.  Beneficial Effects of Kaempferol after Developmental Traumatic Brain Injury Is through Protection of Mitochondrial Function, Oxidative Metabolism, and Neural Viability.

Authors:  Jyothsna Chitturi; Vijayalakshmi Santhakumar; Sridhar S Kannurpatti
Journal:  J Neurotrauma       Date:  2019-01-08       Impact factor: 5.269

Review 3.  The Role of Lipidomics in Autism Spectrum Disorder.

Authors:  Afaf El-Ansary; Salvatore Chirumbolo; Ramesa Shafi Bhat; Maryam Dadar; Eiman M Ibrahim; Geir Bjørklund
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

4.  Hot and Cold Theory: Evidence in Systems Biology.

Authors:  Farideh Bahari; Maryam Yavari
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Impaired hippocampal neurogenesis in vitro is modulated by dietary-related endogenous factors and associated with depression in a longitudinal ageing cohort study.

Authors:  Andrea Du Preez; Sophie Lefèvre-Arbogast; Raúl González-Domínguez; Vikki Houghton; Chiara de Lucia; Dorrain Y Low; Catherine Helmer; Catherine Féart; Cécile Delcourt; Cécile Proust-Lima; Mercè Pallàs; Alex Sánchez-Pla; Mireia Urpi-Sardà; Silvie R Ruigrok; Barbara Altendorfer; Ludwig Aigner; Paul J Lucassen; Aniko Korosi; Claudine Manach; Cristina Andres-Lacueva; Cécilia Samieri; Sandrine Thuret
Journal:  Mol Psychiatry       Date:  2022-07-07       Impact factor: 13.437

6.  Metabolite Profiling Reveals Predictive Biomarkers and the Absence of β-Methyl Amino-l-alanine in Plasma from Individuals Diagnosed with Amyotrophic Lateral Sclerosis.

Authors:  Michael S Bereman; Kaylie I Kirkwood; Tharani Sabaretnam; Sarah Furlong; Dominic B Rowe; Gilles J Guillemin; Allyson L Mellinger; David C Muddiman
Journal:  J Proteome Res       Date:  2020-06-02       Impact factor: 4.466

7.  Acetyl-L-carnitine confers neuroprotection against lipopolysaccharide (LPS) -induced neuroinflammation by targeting TLR4/NFκB, autophagy, inflammation and oxidative stress.

Authors:  Nida Jamali-Raeufy; Fahimeh Alizadeh; Zhila Mehrabi; Soraya Mehrabi; Mina Goudarzi
Journal:  Metab Brain Dis       Date:  2021-03-12       Impact factor: 3.584

8.  Traumatic brain injury metabolome and mitochondrial impact after early stage Ru360 treatment.

Authors:  Jyothsna Chitturi; Vijayalakshmi Santhakumar; Sridhar S Kannurpatti
Journal:  Mitochondrion       Date:  2021-01-21       Impact factor: 4.160

9.  Intergenerational trauma transmission is associated with brain metabotranscriptome remodeling and mitochondrial dysfunction.

Authors:  Sammy Alhassen; Siwei Chen; Lamees Alhassen; Alvin Phan; Mohammad Khoudari; Angele De Silva; Huda Barhoosh; Zitong Wang; Chelsea Parrocha; Emily Shapiro; Charity Henrich; Zicheng Wang; Leon Mutesa; Pierre Baldi; Geoffrey W Abbott; Amal Alachkar
Journal:  Commun Biol       Date:  2021-06-24

Review 10.  Vitamin C Deficiency in the Young Brain-Findings from Experimental Animal Models.

Authors:  Pernille Tveden-Nyborg
Journal:  Nutrients       Date:  2021-05-15       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.